Pleiotropic Effects of Biguanides on Mitochondrial Reactive Oxygen Species Production

Area of Science:

• Biochemistry
• Mitochondrial Metabolism
• Pharmacology

Background:

• Metformin is a primary drug for type 2 diabetes and shows potential in cancer therapy.
• Its precise molecular targets for these effects are not fully understood.
• Research suggests a link between metformin's actions and mitochondrial metabolism, particularly oxidative phosphorylation (OXPHOS).

Purpose of the Study:

• To investigate the direct inhibitory effects of biguanides (metformin and phenformin) on mitochondrial OXPHOS complexes.
• To determine the functional impact of biguanides on the respiratory chain in isolated mitochondria.

Main Methods:

• Isolated brown adipose tissue mitochondria were used as a model system.
• The study assessed the direct inhibitory effects of biguanides on OXPHOS complexes.
• Reactive oxygen species (ROS) production was measured.

Main Results:

• Biguanides showed non-specific inhibition of all respiratory chain dehydrogenases (NADH, succinate, glycerophosphate) but only at very high concentrations (10⁻²–10⁻¹ M).
• These high concentrations far exceed typical cellular concentrations during treatment.
• High biguanide concentrations also induced a burst of reactive oxygen species (ROS), potentially leading to toxicity.

Conclusions:

• The direct inhibitory effect of biguanides on OXPHOS is unlikely to be the primary mechanism for their therapeutic benefits.
• The observed effects at high concentrations, including ROS production and broad OXPHOS inhibition, suggest potential toxicity rather than therapeutic action.
• The beneficial effects of biguanides are likely mediated by more subtle, yet-to-be-identified mechanisms.